CJC-1295 No DAC 2mg is a synthetic growth hormone-releasing hormone (GHRH) analog extensively studied in research for its role in growth hormone secretion pathways. This modified peptide sequence has been investigated for its interactions with GHRH receptors and its influence on pulsatile growth hormone release patterns in laboratory studies.
Research applications have focused on CJC-1295 No DAC’s shorter half-life compared to its DAC-containing counterpart, making it valuable for studies examining natural growth hormone pulse dynamics. Laboratory investigations have explored its mechanism of action in stimulating anterior pituitary somatotroph cells and its downstream effects on IGF-1 signaling cascades.
Each 2mg vial contains high-purity CJC-1295 No DAC in lyophilized powder form, manufactured under strict quality control standards. This compound is sourced from the same supplier as our verified catalog, but the current batch has not yet completed Janoshik Analytical’s independent “Match-Batch” testing. Researchers can check current verification status at the Lab Results page.
When you buy CJC-1295 No DAC online from Bastion Peptides, you receive discreet worldwide shipping with secure packaging. We offer convenient checkout options including credit card and cryptocurrency payments. Our CJC-1295 No DAC for sale includes free re-shipment protection against customs seizure, ensuring reliable delivery for your research protocols.
The 2mg vial size provides optimal quantity for extended research studies while maintaining peptide stability and potency throughout the investigation period.
Research Use Only. Not for human consumption.
Research context
The structure behind the short half-life clarifies why the no-DAC form is selected for pulse studies. CJC-1295 is a synthetic analog of the first 29 amino acids of endogenous GHRH, carrying four substitutions engineered to resist DPP-4 enzymatic degradation. Without the maleimidopropionic acid (MPA) linker that lets the DAC version bind covalently to serum albumin, the no-DAC peptide clears in roughly 30 minutes versus several days for DAC.
That difference shapes the read-out: published research models describe a sharp, pulsatile growth-hormone profile for the no-DAC form, against the sustained, prolonged “bleed” seen with DAC. For that reason it is frequently co-studied alongside ipamorelin, a GHRP, to examine receptor synergy on growth-hormone signaling rather than treated as a standalone secretagogue.
Research guide: DAC vs no-DAC: half-life and release-profile comparison · Verify the lot: check this batch’s Janoshik COA before you buy
Reviews
There are no reviews yet.